The success of cell block preparation is crucial for ancillary diagnostic tests in cytology. However, achieving an optimal cell block can be challenging. The current study describes a self-clotting-based technique for fine-needle aspiration (FNA) cell block preparations and evaluates its usefulness in comparison with the conventional needle wash technique. METHODS: The clinical data, FNA procedure, and cellularity of cell blocks of the self-clotting group (37 cases) and the conventional needle wash group (33 cases) were compared. The cellularity was evaluated using a scoring system (0 indicated acellular, 1 indicated 1-50 cells, and 2 indicated >50 cells). RESULTS: Approximately 76% of cases in the self-clotting group received a score of 2 versus 36% in the conventional needle wash group. Approximately 14% received a score of 1 in the self-clotting group compared with 9% in the conventional needle wash group, whereas 11% in the self-clotting group received a score of 0 versus 55% in the conventional needle wash group. The differences between the 2 methods were statistically significant. CONCLUSIONS: The results of the current study demonstrate that the self-clotting method is superior to the conventional needle wash method for FNA samples.
INTRODUCTION
Cell block is one of the most important sample processing techniques in cytology. In the era of personalized medicine, an optimal cell block becomes crucial because it is the preferred specimen preparation type for the performance of ancillary tests on cytology specimens. 1 More important, cell blocks can preserve samples for future studies. However, due to the small size of the needle used in fine-needle aspiration (FNA), the cell block may lack diagnostic material. Traditionally, the cell block is prepared by collecting needle rinses from an FNA specimen and then concentrating the solution by centrifugation to form a cell pellet. The cell pellet then is hardened using plasma-thrombin or agarose gel, transferred to a histology cassette, fixed in 10% buffered formalin, and further processed into a paraffin block. 1, 2 Although this method is successful in many cases, the efficiency of cellular recovery is not always optimal, ranging from 60% to 90%. 3 There are several factors that contribute to the loss of cellular material during cell block preparation. The FNA specimen is diluted in the liquid medium (saline or balanced salt solution such as Roswell Park Memorial Institute 1640 medium [RPMI]), and a substantial percentage of isolated cells remain in the supernatant fluid after centrifugation and are discarded. Furthermore, the cell pellets harvested by centrifugation are fragile and easily broken down into small pieces and lost during processing. To overcome these limitations, the use of dedicated needle passes and aspiration with larger needles are recommended. In addition, many new techniques of cell block preparation have been described, such as the collodion bag, (A Formalin-Fixed, paraffin-Embedded Cytology cell block Technique) AFFECT, the Cellient Automated Cell Block System (Hologic Inc, Marlborough, Massachusetts), the cell-gel method, etc. [4] [5] [6] [7] These strategies help, but still are insufficient to solve the problem. 8 Yung et al recently described a "tissue coagulum clot" method with which to improve the cellularity of cell blocks. 9 They collected the FNA specimen on a piece of filter paper instead of liquid medium and therefore a blood clot was formed, which then was wrapped into the filter paper and transferred into formalin for fixation and paraffin embedding. They found the cell blocks prepared through "tissue coagulum clot" contained better cellularity compared with the conventional needle wash method. Scraping the clot with a blade from a glass slide also has been shown to facilitate cell block preparation.
1,2
Miller et al even suggested bringing 2 small dropper bottles containing thrombin and plasma separately to the bedside when performing FNA. When there is only a small drop of blood or aspirate on the glass slide from an FNA, adding thrombin or thrombin followed by plasma will cause the FNA material to clot, and it then can be scraped off from the slide for further cell block preparation. 10 In our practice, we noticed that the highest cellular yield is achieved in cell blocks when the aspirate is bloody, leading to visible blood clot formation in the needle wash solution. Based on our observation and the experience of others, 9, 10 we developed a new approach for cell block preparation for FNA specimens, the "self-clotting" method. Instead of washing the needle in RPMI after smears are prepared from each needle pass as we traditionally do, FNA samples dedicated to cell block preparation are expelled entirely into a clean, dry plastic tube and allowed to "self-clot." In the study by Yung et al, filter paper was used to form and collect blood clots, which can be messy and difficult to handle. 9 Therefore, in the current study we chose to use a 50-mL centrifugation tube to collect the bloody FNA samples, which allows blood clots to form directly at the bottom or side wall of the tube. The needle still is washed in RPMI solution, but the needle wash is collected in a separate tube and only after the FNA sample is expelled completely out of the needle. The needle wash solution then is used primarily to dislocate the blood clot from the bottom or side wall of the plastic tube.
The purpose of the current study was to compare the adequacy of cell block preparation using the self-clotting method (SCM) and the conventional needle wash / rinse method (CNRM).
MATERIALS AND METHODS

Data Collection
For the purpose of the current study, we only included cases in which FNAs were performed for superficial or palpable masses using 23-gauge to 25-gauge needles by a pathologist or a radiologist with on-site adequacy assessment by a pathologist. We excluded the following cases: 1) those with only smears and no cell block preparation; 2) image-guided deep-seated FNAs, such as endobronchial and endoscopic ultrasound-guided FNAs; and 3) cases performed by the clinicians, such as surgeons or endocrinologists.
A total of 37 FNAs were performed using the SCM. These cases were collected consecutively from August 1, 2015, to January 20, 2017, once we began using the SCM. All cases were assessed on site for adequacy. These cases served as the study group. We compared the study group with a control group in which FNAs were performed using CNRM 1 year before the current study (January 1, 2014 to July 31, 2015). The control group comprised 33 consecutive FNA cases performed by the same group of cytopathologists and radiologists. All cell blocks were made by rinsing the needle after each pass in RPMI solution.
The cellularity of the cell blocks, number of needle passes, and relevant clinical information (size of the mass, location) for each case using the SCM and CNRM were collected and compared.
The current study was a validation study for the SCM in the cytology laboratory and was not subject to institutional review board approval.
Cytology Smears
Smears were stained with the Diff-Quik method for onsite adequacy assessment.
SCM of Collecting FNA Samples for Cell Block Preparation
For the SCM, there were 8 steps. First, we prepared 2 clean, 50-mL tubes (tubes A and B) and labeled each with patient identification. Tube A was left empty and tube B was filled with 2 to 5 mL of RPMI solution (Fig. 1) . Second, FNA was performed and 1 to 3 passes were dedicated to the cell block with 23 or 25 gauge needles. A 23-gauge needle is recommended because it increases the chance of having blood in the sample. Suction may be applied as needed during FNA. In the current study, the majority of cases were performed with no or minimal suction. Third, the aspirate was expressed directly into the bottom or side wall of tube A and the expelled aspirate was allowed to form a clot and air dry. The air-dried clot normally takes about 2 to 3 minutes to form depending on the amount of the expelled aspirate. Fourth, the needles were washed in the RPMI solution in tube B. Fifth, if the air-dried sample was not bloody or too small in size, 2 drops of plasma were added on the top of the specimen and mixed well; 2 drops of thrombin then were added to form an enlarged artificial clot (Fig. 2) . For the six step, after the clot was formed in tube A, the needle wash RPMI solution was transferred from tube B into tube A. As step seven, the RPMI solution was gently pipetted along the wall to detach the clot from the bottom or side wall of tube A. Finally, the cell block was prepared using the traditional thrombin-plasma method as described below.
CNRM of Collecting FNA Samples for Cell Block Preparation
First, 1 tube labeled with the patient identification and containing 5 mL of RPMI was prepared. Second, FNA was performed with 23-gauge or 25-gauge needles; 1 to 3 passes should be devoted to the cell block. The majority of cases were performed with no or minimal suction. Third, the aspirate was expressed directly into RPMI solution and the needle washed in the solution several times until the needle hub was cleared of aspirate. Finally, the cell block was prepared using the traditional thrombin-plasma method as described below.
Thrombin-Plasma Method for Further Cell Block Preparation
First, RPMI solution was spun down by centrifugation to form a cell pellet and the supernatant fluid decanted. Second, the cell pellet was mixed gently with a few drops of plasma (outdated, from the blood bank). To prevent the pellet from breaking apart, we did not use vortex. Third, the same amount of thrombin was added into the cellplasma mixture. We then waited 1 to 2 minutes for a clot to form. Finally, we removed the clot from the tube, wrapped it with lens paper, and transferred into a cassette for further processing.
Immunohistochemistry
Sections measuring 5 lm in thickness were obtained from the cell block. Immunohistochemistry (IHC) was performed using the BenchMark XT automated IHC staining system (Ventana Medical Systems, Tucson, Arizona). All antibodies used in this study were produced by Ventana Medical Systems.
Evaluation of Data
Sections measuring five lm in thickness were prepared from all cell blocks and stained with routine hematoxylin and eosin. The cellularity of the cell blocks was graded using the following scoring system: 0 indicated no diagnostic cells, 1 indicated that diagnostic cells were present but scant (>0 but <50 cells), and 2 indicated >50 diagnostic cells.
Statistical Analysis
Statistical analysis was performed with Student t tests to compare the cellularity of cell block preparations using the SCM and CNRM. If the 2-tailed P value was <.05, the difference between the 2 groups was considered to be statistically significant.
RESULTS
Clinical Information
In the SCM group, the patients ranged in age from 33 to 91 years (mean, 55.8 years). The male-to-female ratio was 10:27. The size of the aspirated masses ranged from 7 to 0.7 cm (mean, 2.33 cm) ( Table 1) . Seventeen cases (46%) were head and neck lesions, 14 cases (38%) were axillary lymph nodes, 3 cases (8%) were chest wall masses, 1 case (3%) was breast nodules, 1 case (3%) was an inguinal lymph node, and 1 case (3%) was an umbilical region mass. There were 26 cases (70%) of carcinoma, 1 case (3%) of sarcoma, 1 case (3%) of lymphoma, 7 cases (19%) of benign lesions (lymph node hyperplasia, salivary gland, and nodular goiter), and 2 cases (5%) with atypical findings (Table 2 ). In the CNRM group, the patients ranged in age from 11 to 82 years (mean, 54.4 years). The male-to-female ratio was 19:14. The size of the aspirated lesions ranged from 7 to 0.8 cm (mean, 3.11 cm) ( Table 1) . A total of 23 cases (70%) were head and neck lesions, 4 cases (12%) were axillary lymph nodes, 1 case (3%) was a chest wall mass, 1 case (3%) was a breast lesion, 2 cases (6%) were inguinal lymph nodes, 1 case (3%) was an umbilical lesion, and 1 case (3%) was a back lesion. There were 27 cases (82%) of carcinoma, 1 case (3%) of sarcoma, 2 cases (6%) of lymphoma, and 3 cases (9%) of benign lesions (Table 2) .
In summary, the majority of lesions subjected to FNA in both groups were from the head and neck area. Carcinoma was the most common diagnosis ( Table 2 ). The range in the size of the nodules was similar in both groups, but the average size of the nodules in the CNRM group was slightly larger (Table 1) .
Fine-Needle Aspiration
In the SCM group, 17 cases (46%) were palpable lesions and aspirated with the French technique (needle only without suction). The remaining 20 cases (54%) were aspirated with minimal suction through attached syringes. The number of needle passes for each case ranged from 2 to 8 (mean, 4.45 passes). The number of needle passes dedicated to cell block preparation ranged from 1 to 3 (mean, 1.81 passes); specifically, 1 pass in 14 cases (38%), 2 passes in 16 cases (43%), and 3 passes in 7 cases (19%) were used for cell block preparation. In the SCM group, the majority of cases (81%) received 2 needle passes dedicated to cell block.
The cases included in the CNRM group were collected before the validation study, and the application of suction during the FNA procedure was not recorded. The total number of needle passes for each FNA case ranged from 4 to 10 (mean, 5.52 passes). The needle pass dedicated for the cell block ranged from 1 to 6 (mean, 2.82 passes); specifically, 1 pass in 6 cases (18%), 2 passes in 7 cases (21%), 3 passes in 15 cases (45%), and the number of passes was not recorded in 5 cases (15%). In the CNRM group, nearly one-half of the cases (45%) received >2 needle passes dedicated to cell block preparation.
The size of the lesions and number of passes for cell block preparation are summarized in Table 1 .
Cellularity of Cell Blocks
In the SCM group, 28 cases (76%) had a score of 2, 5 cases (14%) had a score of 1, and 4 cases (11%) were scored as 0 (mean score, 1.65) ( Table 1 and Table 3 ) (Fig.  3) . In 6 cases, plasma-thrombin was used on top of the small air-dried aspirate to enhance clot formation either because the aspirate was cystic or the clot was too small. All 6 cases produced satisfactory cell blocks with a cellularity score of 2 (Fig. 4) . Among the cases scored as 2, two cases were originally scored as 0, but no blood clots were observed on the sections. Therefore, 3 extra levels were requested. When the deeper sections revealed the blood clots, the tumor cells also were identified (Fig. 5) . Therefore, these 2 cases were rescored as 2.
In CNRM group, 12 cases (36%) were scored as 2 for cellularity, 3 cases (9%) were scored as 1, and 18 cases (55%) had a score of 0 (mean score, 0.81) ( Table 1 and  Table 3 ). We selected 5 cases scored as 0 from the CNRM group that had received the most number of devoted needle passes (at least 5 in each case) for cell block preparation. Three deeper levels were cut on these cases. They remained with a score of 0 on the deeper levels.
The differences in cellularity between the SCM and CNRM groups were statistically significant (2-tailed P<.0001, Student t test) ( Table 1) . 
IHC Studies
IHC was performed in cell blocks with a cellularity score of 2 in both groups. A total of 28 cases (76%) were scored as 2 in the SCM group. IHC studies were performed on 15 of these 28 cases (54%). Among them, 1 case was stained with 1 marker, 3 cases were stained with 2 markers, 3 cases were stained with 3 markers, and 8 cases were stained with >3 markers. The IHC findings provided critical information with which to make and/or confirm the diagnosis in all 15 cases (100%). Among these 15 cases, 5 had surgical follow-up that confirmed the cytologic diagnosis. The highest number of markers tested in a single case was 16, which was a 5.1-cm chest wall mass. The tumor cells were positive for desmin and myogenin, and therefore this case was diagnosed as "sarcoma with muscle differentiation." The subsequent surgical excision revealed a high-grade rhabomyosarcoma (Fig. 6) .
In the CNRM group, 12 of 33 cases (36%) were scored as 2. IHC studies were performed on all of these cases, but were noncontributory in 2 cases due to scant cellularity on the deeper levels. Therefore, IHC was only successful in 10 of 12 cases (83%). Two cases were stained with 1 marker, 3 cases were stained with 2 markers, 2 cases were stained with 3 markers, and 3 cases were stained with >3 markers.
When comparing these 2 groups, more cases in the SCM group were found to have adequate cellularity for IHC (76%) versus the CNRM group (36%). Furthermore, IHC when performed was successful and informational in 100% of the cases in the SCM group versus 83% of the cases in the CNRM group.
Molecular Studies
In the SCM group, 2 cases diagnosed as metastatic lung cancer successfully underwent molecular studies (lung panel including epidermal growth factor receptor, RAS, and ALK mutations). One of these cases was positive for the KRAS mutation. The other was negative for all mutations.
In the CNRM group, molecular studies (lung panel) were attempted in 1 case, but due to scant cellularity, only the epidermal growth factor receptor test was performed and was negative.
DISCUSSION
The results of the current study demonstrate that the SCM improves the cellularity of cell block preparations for FNA. This approach protects the cellular components in the FNA sample from dispersing into the collection medium and prevents the loss of dispersed cells during subsequent processing. In addition, it decreases the number of needle passes required for an adequate cell block. Although we did not include image-guided FNAs of deep-seated lesions (liver, lung, pancreas, etc) in the current study, we believe that this conclusion will also be true in those cases because FNA in deep-seated lesions normally is performed with larger needles and has a much higher chance of containing some amount of blood with which to form a solid blood clot. In the study by Yung et al, 9 all cases were endobronchial ultrasound-guided transbronchial FNA. The improvement in cell block cellularity induced by the SCM was evident in their study. 9 We tried the SCM on 2 cases of endobronchial ultrasound-guided transbronchial FNA specimens in the study institution, which worked very well. However, the sample size was too small to be included in the current study. Further investigation is in progress.
Although we used the plasma-thrombin method for cell block preparation in the current study, we believe that the SCM also can be equally effective with the agarose gel method. Once the air-dried blood clot is formed, formalin fixation can be performed.
1,2 After disposing the formalin, liquefied agarose gel is added in, mixed well, and cooled down to solidify the sample for further cell block preparation.
A limitation of the current study was that the SCM and CNRM were not performed on the same patients. However, the size and location of the aspirated lesions were similar in the 2 groups. The FNA procedures for both the SCM and CNRM groups were performed by the same set of cytopathologists and radiologists, which minimized the operator factor.
Although benchtop FNA on fresh surgical specimens may be the most ideal model for the current study, we found that the majority of surgical specimens in the study institution are put in formalin before arriving at the pathology grossing room. In addition, clotting is a delicate physiological process regulated by many clotting factors that are easily degraded once the specimen is removed from the body. In our pilot validation study, we were unable to make blood clots using benchtop FNA material obtained from the surgical specimens.
Cell block preparation is an old technique. Its history dates back to 1896, when effusion fluid was the major specimen type in cytology. The first cell block was prepared from the sediment of ascitic fluid.
11 Many investigators described methods with which to improve the cellular yield of cell block preparations, such as the collodion bag, AFFECT, the Cellient Automated Cell Block System (Hologic Inc), the cell-gel method, etc. [4] [5] [6] [7] They all adopted the same philosophy of harvesting cells from the needle rinse of FNA samples collected in a liquid medium. Our approach is different from the above studies because we believe that part of the challenge of achieving adequate cellularity is due to the dilution of the aspirate when it is rinsed into a liquid medium. The results of the current study demonstrated that expelling all FNA material into a dry container is much more efficient for harvesting cellular material than needle rinses in liquid medium. The concentrated form of FNA sample acquired in the needle needs to remain concentrated to minimize cellular loss induced by placing the sample directly in a liquid medium. Cellular preservation may be of concern when FNA samples are expelled into an empty dry test tube. Blood from the patients is the best medium with which to preserve cellular material from their own FNA samples. The principle of air drying has been widely used with regard to FNA smear slide preparation, in which it serves as a method for both fixation and enhancing cellular adherence to the glass slide. It has been demonstrated by many studies that immunostains can be successfully performed on airdried smear slides. 2, 12 Approximately 50% of cases scored as 2 in the SCM group (15 of 28 cases) had IHC studies performed and none demonstrated aberrant results, which supports our conclusion that the cell blocks prepared by the SCM are suitable for IHC. In the current study, there were 2 cases in the SCM group that originally were scored as 0 for cellularity. However, when we cut deeper into the block until the blood clot was observed, the tumor cells wrapped in the clot also were identified (Fig. 5) . Therefore, these 2 cases were rescored as 2. This observation indicates that the blood clot can be used as a natural marker with which to indicate proper sectioning depth. The cell block with no visible blood clot on the sections needs to be cut deeper before it is deemed acellular. The level indicator unfortunately could not be appreciated in the CNRM group because the cells were dispersed randomly and evenly into the cell blocks; therefore, deeper levels most likely will not yield more material. In the current study, we selected 5 cases scored as 0 from the CNRM group that had received the most number of devoted needle passes (at least 5 passes in each case) for cell block preparation. None demonstrated an improvement in the cell block cellularity on deeper levels.
There were 4 cases in the SCM group with a cellularity score of 0. None of these cases demonstrated blood clots on the original and deeper levels. This observation indicates that blood clots were not formed properly in those cases or that the clots were too thin or too small to survive processing. These cases were at the earlier stage of the current study. We later began to use plasma-thrombin to enhance clot formation for those cases when the clot was too small (<5 mm) or too thin (light can be visualized through the clot) (Figs. 2 and 4) . The small air-dried clot is wrapped into a bigger gelatin ball formed by plasma-thrombin, and therefore it can be picked up easily and put into a tea bag for the subsequent cell block preparation.
